Brian B.  Yoor net worth and biography

Brian Yoor Biography and Net Worth

I currently serve as Chairman and Strategic Advisor for a unique Life Sciences Venture Investment Company, Portal Innnovations, that utilizes "crafted capital" consisting of physical space, financial capital and management expertise to fuel the growth of innovative start-ups. I also am a global financial executive with 30 years of experience in strategy, finance, operations, investor relations, acquisitions and integrations and organizational development. For 5 years, I served as the Chief Financial Officer of Abbott, a global leader in healthcare, where I successfully built and led performance culture and transformative change in the areas of capital allocation, enterprise-wide cash flow, and investor relations. My background includes extensive work with the Audit Committee and the entire Board of Directors. During my tenure as CFO, Abbott’s market capitalization more than doubled with returns well exceeding the market indices. I pride myself on being a teacher, coach and mentor to build outstanding organizations.

What is Brian B. Yoor's net worth?

The estimated net worth of Brian B. Yoor is at least $17.69 million as of January 28th, 2020. Mr. Yoor owns 155,610 shares of Abbott Laboratories stock worth more than $17,691,301 as of March 28th. This net worth estimate does not reflect any other assets that Mr. Yoor may own. Learn More about Brian B. Yoor's net worth.

How do I contact Brian B. Yoor?

The corporate mailing address for Mr. Yoor and other Abbott Laboratories executives is 100 ABBOTT PARK ROAD D-322 AP6D, ABBOTT PARK IL, 60064. Abbott Laboratories can also be reached via phone at (224) 667-6100. Learn More on Brian B. Yoor's contact information.

Has Brian B. Yoor been buying or selling shares of Abbott Laboratories?

Brian B. Yoor has not been actively trading shares of Abbott Laboratories during the last quarter. Most recently, Brian B. Yoor sold 509,850 shares of the business's stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $89.73, for a transaction totalling $45,748,840.50. Following the completion of the sale, the chief financial officer now directly owns 155,610 shares of the company's stock, valued at $13,962,885.30. Learn More on Brian B. Yoor's trading history.

Who are Abbott Laboratories' active insiders?

Abbott Laboratories' insider roster includes Hubert Allen (Insider), Roxanne Austin (Director), Roger Bird (SVP), Brian Blaser (Insider), Philip Boudreau (VP), Sharon Bracken (Insider), John Capek (EVP), Jaime Contreras (SVP), Michael Dale (SVP), Lisa Earnhardt (EVP), Robert Ford (Chairman), Robert Ford (CEO), Robert Funck (CFO), Stephen Fussell (EVP), John Ginascol (EVP), Sammy Karam (SVP), Michelle Kumbier (Director), Andrew Lane (EVP), Joseph Manning (SVP), Nancy Mckinstry (Director), Mary Moreland (EVP), Louis Morrone (SVP), Phebe Novakovic (Director), Michael Pederson (SVP), Daniel Salvadori (EVP), Christopher Scoggins (SVP), Daniel Starks (Director), Julie Tyler (SVP), Andrea Wainer (EVP), Jared Watkin (SVP), Miles White (Chairman), Randel Woodgrift (SVP), and Brian Yoor (CFO). Learn More on Abbott Laboratories' active insiders.

Are insiders buying or selling shares of Abbott Laboratories?

During the last year, insiders at the healthcare product maker sold shares 10 times. They sold a total of 240,061 shares worth more than $26,014,576.06. The most recent insider tranaction occured on March, 1st when EVP Daniel Gesua Sive Salvadori sold 963 shares worth more than $114,115.50. Insiders at Abbott Laboratories own 1.1% of the company. Learn More about insider trades at Abbott Laboratories.

Information on this page was last updated on 3/1/2024.

Brian B. Yoor Insider Trading History at Abbott Laboratories

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/28/2020Sell509,850$89.73$45,748,840.50155,610View SEC Filing Icon  
8/8/2019Sell43,763$85.77$3,753,552.51125,781View SEC Filing Icon  
3/1/2019Sell2,246$78.00$175,188.00116,627View SEC Filing Icon  
6/1/2016Sell565$39.49$22,311.8550,182View SEC Filing Icon  
2/29/2016Sell865$39.12$33,838.8052,250View SEC Filing Icon  
See Full Table

Brian B. Yoor Buying and Selling Activity at Abbott Laboratories

This chart shows Brian B Yoor's buying and selling at Abbott Laboratories by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Abbott Laboratories Company Overview

Abbott Laboratories logo
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Read More

Today's Range

Now: $113.69
Low: $113.09
High: $113.94

50 Day Range

MA: $115.14
Low: $110.01
High: $120.98

2 Week Range

Now: $113.69
Low: $89.67
High: $121.64

Volume

521,466 shs

Average Volume

5,667,615 shs

Market Capitalization

$197.27 billion

P/E Ratio

34.87

Dividend Yield

1.97%

Beta

0.75